Your daily dose of the clinical news you may have missed.
Women referred from obstetrics to primary care postpartum via a pilot program were more likely to attend a PCP visit than nonreferred women.
Your daily dose of the clinical news you may have missed.
More advanced practice clinicians and fewer physicians are providing contraception services, researchers reported.
An overview of safe treatment options for migraine attacks that may occur during pregnancy for primary care clinicians, here.
First nonprescription daily oral contraceptive pill, OTC opioid antagonist nasal spray for opioid overdose, and 5 more FDA-approved drugs primary care clinicians should know about.
Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.
Results from a new study suggest that postnatal SSRI treatment may be beneficial in the long term for both women with postpartum depression and their children.
The FDA approved Abrysvo for use in pregnant individuals to prevent LRTD and severe LRTD caused by RSV in infants from birth through 6 months of age.
The US FDA approved zuranolone 50 mg as the first oral, once-daily treatment for postpartum depression in adults.